Source comparison
Thymalfasin Same as Thymosin Alpha-1: Mechanism Comparison
Amino Acid Sequence 28-residue peptide (Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN-OH) None. Sequences are identical Molecular Weight 3,108 Da None. Same molecular structure Receptor Target Toll-like receptor 9 (TLR9) on dendritic cells None. Binds identical receptor Pri
This comparison does not assign a generated winner or score.
- Amino Acid Sequence
- 28-residue peptide (Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN-OH)
- None. Sequences are identical
- Molecular Weight
- 3,108 Da
- None. Same molecular structure
- Receptor Target
- Toll-like receptor 9 (TLR9) on dendritic cells
- None. Binds identical receptor
- Primary Mechanism
- Upregulates IL-12 and IFN-γ, shifts immune response to Th1
- None. Activates same cytokine pathway
- Typical Research Dose
- 1.6 mg subcutaneous injection, twice weekly
- None. Dosing protocols identical
- Bottom Line
- Thymalfasin is the pharmaceutical trademark for synthetic thymosin alpha-1. No structural, functional, or dosing difference exists between the two names.